Language

Mezym forte 10000 capsules — packaging
Packaging may differ

Mezym forte 10000 capsules prices in Yerevan pharmacies

pancreatin · capsules hard gastro-resistant · 10000 U + not less than 9000 U + not less than 500 U · over the counter

Menarini International Operations Luxembourg S.A. · Germany

Registration No. 20078 · valid until 18 Oct 2026

  • Over the counter

Prices at 2 online pharmacies

20 pcs · by pack price · prices from pharmacy websites as of 15 Oct 2026

in stock · out of stock · no mark — the pharmacy does not report stock⁠About these prices

These are prices of the pharmacy chains' online shops, not of a particular branch. The list is sorted by pack price; pharmacies where the medicine is out of stock come last.

“≈ … per unit” is Medaro’s calculation: the pack price divided by the number of units (for liquids and ointments — per 10 ml or 10 g), rounded.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Product record

Trade name
Mezym forte 10000 capsules
Active ingredient (INN)
pancreatin (lipase, amylase, protease)
ATC code
A09AA02
Registration certificate
No. 20078,
Dispensing
Over the counter

The register has no link to the official leaflet yet — read the leaflet in the pack.

State Register of Medicines (pharm.am) (opens in a new tab)
Show all detailsHide details
Dosage form
capsules hard gastro-resistant
Strength
10000 U + not less than 9000 U + not less than 500 U
Marketing authorisation holder
Menarini International Operations Luxembourg S.A.,1, avenue de la Gare, 1611, Luxembourg
Manufacturer
Berlin-Chemie A.G.,Glienicker Weg 125, 12489 Berlin- batch releaser, Adare Pharmaceuticals Srl., Via Martin Luther King, 13, Pessano Con Bornago, 20060, Italy- bulk manufacturer, quality control, Artesan Pharma GmbH & Co. KG, Albrecht-Thaer-Str. 9, 29439 Luchow, Germany- packager
Country
Germany

Details from the State Register of Medicines of Armenia as of 31 Aug 2026. No indications, directions for use or dosing regimen here — read the official leaflet.

Spotted an error? Let us know

As a rule, we will send you a confirmation that your message has been received and, once the check is done, its outcome. We need your address only for emails about this message: it is not published on the site and is not added to any mailing list. Privacy policy